Anastasios Arima
Known title: Chief Executive OfficerCIK: 0001864247
Anastasios Arima's purchase track record
Anastasios Arima has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 7/10/2026 | IPX | $497K | -34.2% | pending | — |
| 4/28/2026 | IPX | $494K | -27.8% | pending | — |
| 3/27/2026 | IPX | $1.79M | +14.5% | -15.3% | +21.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| IPX | ▲ Buy | Open Market | 138,720 | $497K | 7/10/2026 | View on chart |
| IPX | ▲ Buy | Open Market | 110,000 | $494K | 4/28/2026 | View on chart |
| IPX | ▲ Buy | Open Market | 467,000 | $1.5M | 3/27/2026 | View on chart |
| IPX | ▲ Buy | Open Market | 12,800 | $300K | 3/27/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
IPX Gets Analyst Coverage, Second U.S. Army Task Order for Titanium
IperionX received a second task order from the U.S. Army focused on accelerating industrial-scale American titanium production, marking continued government engagement with the company's manufacturing capabilities. Separately, Jefferies initiated analyst coverage of the stock with a $26 price target, bringing more institutional attention to the company. The analyst consensus price target across six firms stands at $45.50, with individual targets ranging from $26 to $55. These developments signal growing both government and institutional interest in IperionX's domestic titanium production operations.
IPX Gets Analyst Coverage, Second U.S. Army Task Order for Titanium. IperionX received a second task order from the U.S. Army focused on accelerating industrial-scale American titanium production, marking continued government engagement with the company's manufacturing capabilities. Separately, Jefferies initiated analyst coverage of the stock with a $26 price target, bringing more institutional attention to the company. The analyst consensus price target across six firms stands at $45.50, with individual targets ranging from $26 to $55. These developments signal growing both government and institutional interest in IperionX's domestic titanium production operations.